Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Engineered T Cell Therapy for Breast Cancer
Recruiting1 awardPhase 1
Los Angeles, California
This trial tests a special type of immune cell therapy to treat TNBC that has come back or does not respond to treatment. Chemotherapy drugs and IL-2 help the T cells attack and kill tumor cells that express NY-ESO-1.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service